These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 23483542)
41. Molecular dynamics analysis of the aggregation propensity of polyglutamine segments. Wen J; Scoles DR; Facelli JC PLoS One; 2017; 12(5):e0178333. PubMed ID: 28542401 [TBL] [Abstract][Full Text] [Related]
42. Polyglutamine expansion diseases: More than simple repeats. Silva A; de Almeida AV; Macedo-Ribeiro S J Struct Biol; 2018 Feb; 201(2):139-154. PubMed ID: 28928079 [TBL] [Abstract][Full Text] [Related]
43. Diphenyl diselenide protects a Caenorhabditis elegans model for Huntington's disease by activation of the antioxidant pathway and a decrease in protein aggregation. Bicca Obetine Baptista F; Arantes LP; Machado ML; da Silva AF; Marafiga Cordeiro L; da Silveira TL; Soares FAA Metallomics; 2020 Jul; 12(7):1142-1158. PubMed ID: 32453327 [TBL] [Abstract][Full Text] [Related]
44. Conformational behavior and aggregation of ataxin-3 in SDS. Saunders HM; Hughes VA; Cappai R; Bottomley SP PLoS One; 2013; 8(7):e69416. PubMed ID: 23894474 [TBL] [Abstract][Full Text] [Related]
45. A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal Huntingtin's polyglutamine stretch on CAG140 mouse model pathogenesis. Zheng S; Ghitani N; Blackburn JS; Liu JP; Zeitlin SO Mol Brain; 2012 Aug; 5():28. PubMed ID: 22892315 [TBL] [Abstract][Full Text] [Related]
47. Polyglutamine induced misfolding of huntingtin exon1 is modulated by the flanking sequences. Lakhani VV; Ding F; Dokholyan NV PLoS Comput Biol; 2010 Apr; 6(4):e1000772. PubMed ID: 20442863 [TBL] [Abstract][Full Text] [Related]
48. Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation. Minakawa EN; Popiel HA; Tada M; Takahashi T; Yamane H; Saitoh Y; Takahashi Y; Ozawa D; Takeda A; Takeuchi T; Okamoto Y; Yamamoto K; Suzuki M; Fujita H; Ito C; Yagihara H; Saito Y; Watase K; Adachi H; Katsuno M; Mochizuki H; Shiraki K; Sobue G; Toda T; Wada K; Onodera O; Nagai Y Brain; 2020 Jun; 143(6):1811-1825. PubMed ID: 32436573 [TBL] [Abstract][Full Text] [Related]
49. RNAi for the large non-coding hsromega transcripts suppresses polyglutamine pathogenesis in Drosophila models. Mallik M; Lakhotia SC RNA Biol; 2009; 6(4):464-78. PubMed ID: 19667761 [TBL] [Abstract][Full Text] [Related]
50. p97 Homologs from Caenorhabditis elegans, CDC-48.1 and CDC-48.2, suppress the aggregate formation of huntingtin exon1 containing expanded polyQ repeat. Nishikori S; Yamanaka K; Sakurai T; Esaki M; Ogura T Genes Cells; 2008 Aug; 13(8):827-38. PubMed ID: 18782221 [TBL] [Abstract][Full Text] [Related]
51. The Protein Structure Context of PolyQ Regions. Totzeck F; Andrade-Navarro MA; Mier P PLoS One; 2017; 12(1):e0170801. PubMed ID: 28125688 [TBL] [Abstract][Full Text] [Related]
52. A key lysine residue in the AXH domain of ataxin-1 is essential for its ubiquitylation. Kang AR; Park SH; Lee S; Choi DY; Kim KP; Song HK; Hong S; Kang S Biochim Biophys Acta; 2015 May; 1854(5):356-64. PubMed ID: 25641559 [TBL] [Abstract][Full Text] [Related]
53. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3. Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810 [TBL] [Abstract][Full Text] [Related]
54. Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein. Saunders HM; Gilis D; Rooman M; Dehouck Y; Robertson AL; Bottomley SP Protein Sci; 2011 Oct; 20(10):1675-81. PubMed ID: 21780213 [TBL] [Abstract][Full Text] [Related]
55. p62 plays a protective role in the autophagic degradation of polyglutamine protein oligomers in polyglutamine disease model flies. Saitoh Y; Fujikake N; Okamoto Y; Popiel HA; Hatanaka Y; Ueyama M; Suzuki M; Gaumer S; Murata M; Wada K; Nagai Y J Biol Chem; 2015 Jan; 290(3):1442-53. PubMed ID: 25480790 [TBL] [Abstract][Full Text] [Related]
56. Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity. Suzuki E; Zhao Y; Ito S; Sawatsubashi S; Murata T; Furutani T; Shirode Y; Yamagata K; Tanabe M; Kimura S; Ueda T; Fujiyama S; Lim J; Matsukawa H; Kouzmenko AP; Aigaki T; Tabata T; Takeyama K; Kato S Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3818-22. PubMed ID: 19237573 [TBL] [Abstract][Full Text] [Related]
57. Lithium chloride alleviates neurodegeneration partly by inhibiting activity of GSK3β in a SCA3 Drosophila model. Jia DD; Zhang L; Chen Z; Wang CR; Huang FZ; Duan RH; Xia K; Tang BS; Jiang H Cerebellum; 2013 Dec; 12(6):892-901. PubMed ID: 23812869 [TBL] [Abstract][Full Text] [Related]
58. Dynamic imaging by fluorescence correlation spectroscopy identifies diverse populations of polyglutamine oligomers formed in vivo. Beam M; Silva MC; Morimoto RI J Biol Chem; 2012 Jul; 287(31):26136-45. PubMed ID: 22669943 [TBL] [Abstract][Full Text] [Related]
59. Structural basis for recognition of the third SH3 domain of full-length R85 (R85FL)/ponsin by ataxin-7. Jiang YJ; Zhou CJ; Zhou ZR; Wu M; Hu HY FEBS Lett; 2013 Sep; 587(18):2905-11. PubMed ID: 23892081 [TBL] [Abstract][Full Text] [Related]
60. Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation. Johnson SL; Ranxhi B; Libohova K; Tsou WL; Todi SV Elife; 2020 Sep; 9():. PubMed ID: 32955441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]